ZFHX3 and neoplasm: Acting as a tumor suppressor, ZFHX3 has been implicated in prostate and breast cancers, and is frequently mutated in microsatellite unstable endometrial (36%) and colorectal (approximately 40%) tumors [11, 50–52].